Skip to main content
MANIFOLD
Will any clinical trial on STAR-T cell immunotherapy in solid tumors be announced in 2023?
3
Ṁ110Ṁ85
resolved Jan 20
Resolved
NO

Market context
New Year's Resolutions 2024
Get
Ṁ1,000
to start trading!

🏅 Top traders

#TraderTotal profit
1Ṁ36
2Ṁ8

People are also trading

Will tabernanthalog (TBG) undergo Stage II clinical trials by EOY 2026?
36% chance
Will cevumeran start a Phase III trial for pancreatic cancer by 2030?
57% chance
Which immunotherapy companies will be around in 2028?
Will I get follistatin gene therapy by EOY 2026?
26% chance
Will a cancer therapy approved by the FDA before 2027 successfully cure >1 cancer type?
69% chance
Will AOH1996 advance past Phase II trials by the end of 2027?
43% chance
Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
21% chance
Will a novel therapeutic/device which confers a survival benefit for glioblastoma be FDA approved by EOY 2028?
51% chance
Will the FDA approve MAIA Biotechnology's THIO-101 for the treatment of advanced Non-Small Cell Lung Cancer by Jan 2030?
84% chance
Will the pre-clinical results on the cancer drug AOH1996 be broadly confirmed by independent team(s)?
26% chance
Sort by:

⚠Unreceptive to pings ; AFK Creator

📢Resolved to NO

@SarahC Can you please resolve? Thank you!

@traders Any proof of YES before this resolves NO? I could find no proof of such specific trial in all my research.

predictedYES

@SirCryptomind seems I'm the only yes holder. I have nothing

People are also trading

Will tabernanthalog (TBG) undergo Stage II clinical trials by EOY 2026?
36% chance
Will cevumeran start a Phase III trial for pancreatic cancer by 2030?
57% chance
Which immunotherapy companies will be around in 2028?
Will I get follistatin gene therapy by EOY 2026?
26% chance
Will a cancer therapy approved by the FDA before 2027 successfully cure >1 cancer type?
69% chance
Will AOH1996 advance past Phase II trials by the end of 2027?
43% chance
Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
21% chance
Will a novel therapeutic/device which confers a survival benefit for glioblastoma be FDA approved by EOY 2028?
51% chance
Will the FDA approve MAIA Biotechnology's THIO-101 for the treatment of advanced Non-Small Cell Lung Cancer by Jan 2030?
84% chance
Will the pre-clinical results on the cancer drug AOH1996 be broadly confirmed by independent team(s)?
26% chance